CNET: FDA authorizes AstraZeneca COVID prevention drug for immunocompromised people

CNET: FDA authorizes AstraZeneca COVID prevention drug for immunocompromised people. “On Wednesday, the US Food and Drug Administration gave emergency use authorization to a monoclonal antibody drug made by AstraZeneca that helps prevent COVID-19 in people who have compromised immune systems or those who have a history of a severe allergic reaction to the coronavirus vaccines.”

Leave a Reply

%d bloggers like this: